Oral presentations
Publications
Presentations
HIV/AIDS in seniors: Four years experience in providing access to antiretroviral therapy (ART) to older adults in a managed healthcare setting
Hislop M, Regensberg L. HIV/AIDS in seniors: Four years experience in providing access to antiretroviral therapy (ART) to older adults in a managed healthcare setting. Geriatrix Africa Conference, Cape Town, March 2003.
Optimizing tools for measuring short-term antiretroviral adherence from pharmacy refill data to predict virologic outcomes in resource limited settings
Leisegang R, McMahon J, Little F, Elliott J, Hislop M, Maartens G. Optimizing tools for measuring short-term antiretroviral adherence from pharmacy refill data to predict virologic outcomes in resource limited settings. 8th International AIDS Society Conference, Vancouver, Canada, 19 – 22 July 2015.
Determinants of resistance to second-line protease inhibitor-based antiretroviral therapy in the Southern African private sector
Cohen K, Stewart A, Leisegang R, Coetsee M, Maharaj S, Dunn L, Hislop M, Regensberg L, Meintjes G, van Zyl G, Maartens G. Determinants of resistance to second-line protease inhibitor-based antiretroviral therapy in the Southern African private sector. South African HIV Clinicians Society Conference, Cape Town, September 2014.
Efficacy of third line ART in Africa: outcomes on ART salvage regimens in the Southern African private sector
Dunn L, Coetsee M, Hislop M, Regensberg L, Maartens G, Meintjes G. Efficacy of third line ART in Africa: outcomes on ART salvage regimens in the Southern African private sector. 7th European & Developing Countries Clinical Trials Partnership (EDCTP) Forum, Berlin, 1 July 2014.
A current review of the insurability and survival of lives living with HIV and other chronic disease
Sarkin L, Leisegang R. A current review of the insurability and survival of lives living with HIV and other chronic disease. 30th International Congress of Actuaries 2014, Washington, D.C., United States, 30 March – 4 April 2014.
Excellent Adherence to Antiretroviral Therapy Predicts Lower Direct Health Care Costs for HIV-infected Adults
Nachega J, Leisegang R, Hislop M, Cleary S, Bishai D, Nguyen H, Regensberg L, Maartens G. Excellent Adherence to Antiretroviral Therapy Predicts Lower Direct Health Care Costs for HIV-infected Adults. South African AIDS Conference, Durban April 2009.
HIV-1 infected adolescents: treatment experience in a managed care setting in South Africa
Matoti L., Hislop M.S., Regensberg L.D., Cotton M. HIV-1 infected adolescents: treatment experience in a managed care setting in South Africa. South African AIDS Conference, Durban June 2007.
Efavirenz vs. Nevirapine-based Antiretroviral Therapy Regimens: Adherence and Virologic Outcomes
Nachega J, Hislop M, Dowdy D, Regensberg L, Chaisson R, Maartens G. Efavirenz vs. Nevirapine-based Antiretroviral Therapy Regimens: Adherence and Virologic Outcomes. 14th Conference on Retroviruses and Opportunistic Infections (CROI), Los Angeles, Calif., USA Feb 25-28, 2007.
HAART Adherence to NNRTIs-based Regimen and Virologic Outcomes in HIV-infected South Adults
Nachega J, Hislop M, Dowdy D, Regensberg L, Chaisson R, Maartens G. HAART Adherence to NNRTIs-based Regimen and Virologic Outcomes in HIV-infected South Adults. 13th Conference on Retroviruses and Opportunistic Infections (CROI), Denver, Colo., USA Feb 5-9, 2006.
HAART Adherence as assessed by Pharmacy Claims Predicts Survival in HIV-infected South African Adults
J.B.Nachega, M.S.Hislop, D.Dowdy, M.Lo, O.Saad, L.D.Regensberg, R.E.Chaisson, G.Maartens. HAART Adherence as assessed by Pharmacy Claims Predicts Survival in HIV-infected South African Adults. 12th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, Mass., USA Feb 22-25, 2005, Ab#Or25.